Project cooperationUpdated on 22 January 2026
Clinical partners for a buccal drug delivery platform for complex APIs (inlcuding Medical Cannabis)
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain
About
We are seeking collaboration partners to support the clinical development and validation of a buccal drug delivery platform for complex APIs, with an initial focus on psychiatric indications and substance use disorders.
We are particularly interested in collaborating with:
– Clinical Research Organisations (CROs) experienced in early-phase clinical trials (Phase I/II), pharmacokinetics and psychiatric or addiction-related studies
– Digital health or AI companies providing platforms for clinical data structuring, adherence monitoring and real-world evidence generation
– Pharmaceutical or biotech laboratories active in the psychiatry or addiction medicine ecosystem
Potential collaborations include participation in Horizon Europe collaborative projects, clinical feasibility studies, observational or interventional trials, and joint development of clinical and digital tools to support treatment standardisation and outcome measurement.
The platform is compatible with botanical-derived and complex APIs, including regulated medical cannabis-based active substances, developed under pharmaceutical quality and clinical research standards.
Topic
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research
Type
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
Investment and co-development partners for a buccal drug delivery platform (TRL 5 → TRL 6)
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
David Molinero Caravantes
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain
Project cooperation
Digital Psychiatry and Youth Mental Health Research for Innovative Health Projects
- Partner seeks Consortium/Coordinator
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
MARCO BERZANO
Research Manager and Advisor - Head of Medical Area at Università Politecnica delle Marche
Ancona, Italy
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Maria Alexandra Rujano
Project Manager at European Clinical Research Infrastructure Network (ECRIN)
Paris, France